OpenAI CEO Sam Altman announced that the company will delay its planned IPO beyond 2026, stating that going public now would be "ill-advised." The decision is driven by rising safety risks in AI development and the need for better alignment between technology, industry, and government. Altman also highlighted internal governance challenges due to OpenAI's dual non-profit and for-profit structure, which complicates decisions that prioritize mission over shareholder interests. The company may join other AI labs in a pact to slow AI progress to address safety concerns, with 2027 now seen as a more likely IPO timeline. Investors should watch for any formal safety agreements, Anthropic's IPO progress, and whether AI development pauses are implemented.
The Human Feedback Foundation, supported by RBC, has launched the Agentic AI Design Exchange, a national program aimed at helping Canadian nonprofits design, build, and deploy AI agents responsibly. Funded through RBC's Stronger Nonprofits Program, t...
Satellos Bioscience Inc., a clinical-stage company focused on treatments for degenerative muscle diseases, announced its management will participate in two investor conferences in November: the Guggenheim Healthcare Innovation Conference on Nov 9 in ...
YYForce Inc. has purchased 20 wearable data collection systems to gather real task data from hotel room service at Novotel Singapore. This project aims to record and analyze experienced staff performing tasks like bed-making, towel folding, and clean...
The global digital health and remote patient monitoring market is projected to grow from $26.8 billion in 2025 to $80.8 billion by 2031, at a compound annual growth rate of 20.2%. This growth is driven by increasing demand for chronic disease managem...
The global private credit and alternative lending market, valued at $2.31 trillion in 2026, is expected to grow at a 7.8% CAGR to reach $3.36 trillion by 2031. Recent liquidity pressures in 2025, triggered by bankruptcies and AI sector concerns, caus...
